,,ii  #aahth ,,congress  #ast ,session  
,s4 #adda  ,,in ,,the ,,senate ,,of     
,,the ,,united ,,states  ,may #d1       
#bjbc,mr4 ,cornyn 7for himself and ,mr4 
,kaine7 introduced the following bill2  
which was read twice and referred to the
 ,committee on ,health1 ,education1     
,labor1 and ,pensions  ,a ,,bill  ,to   
establish a ,center for ,biomedical     
,innovation and ,development in order to
 accelerate innovation and development  
of advanced medical countermeasure      
products4  #a4 ,short title ,this ,act  
may be cited as the ,accelerating       
,biomedical ,innovation ,act4  #b4      
,center for biomedical innovation and   
development program ,title ,,iii of the 
,public ,health ,service ,act 7#db      
,u4,s4,c4 #bda et seq47 is amended by   
inserting after section #cai,l-#a the   
following3  #cai,l-#b4 ,center for      
biomedical innovation and development   
program  7a7 ,establishment of          
consortium ,not later than #a year after
 the date of enactment of this section1 

the ,secretary shall establish a        
consortium of not fewer than #c         
institutions of higher education 7as    
defined in section #aja of the ,higher  
,education ,act71 to accelerate         
innovation and development of advanced  
medical countermeasure products1        
including biological products and       
devices1 selected by the ,biomedical    
,advanced ,research and ,development    
,agency 7referred to in this section as 
,,barda74 ,such consortium shall be     
known as the ,center for ,biomedical    
,innovation and ,development 7referred  
to in this section as the ,center74  7b7
 ,selection of participating            
institutions ,in selecting institutions 
of higher education to participate in   
the ,center under subsection 7a71 the   
,secretary shall-- 7#a7 select eligible 
institutions that have-- 7,a7 expertise 
and capabilities in current good        
manufacturing practices1 as defined in  
part #aag of title #ba ,code of ,federal
 ,regulations 7or successor             

regulations72  7,b7 experience in       
technology innovation1 including        
advanced manufacturing technologies1    
that may assist in countermeasure and   
advanced research and development2  7,c7
 facilities with flexible and adaptable 
advanced process development            
capabilities2 and  7,d7 other relevant  
qualifications1 as determined by the    
,secretary2  7#b7 select at least one   
institution with the capability to      
handle secure and classified            
information1 as appropriate2 and  7#c7  
prioritize institutions most likely to  
aid in the advancement and innovation of
 the medical countermeasure products1   
the manufacturing processes for such    
products1 and the execution and design  
of clinical trials4  7c7 ,center        
activities ,the ,center established     
under subsection 7a7 shall assist public
 and private entities in accelerating   
nonclinical research discoveries with   
respect to medical countermeasures      
through advanced development and        

clinical trials4 ,the activities of the 
,center may include-- 7#a7 advanced     
process development and pilot           
manufacturing to support clinical       
trials2  7#b7 technical assistance2     
7#c7 contract award management2  7#d7   
referral and coordination with potential
 manufacturing partners2  7#e7          
regulatory assistance2  7#f7 technology 
transfer2 and  7#g7 program management4 
7d7 ,eligible products ,a drug or device
 7including a combination of one or more
 drugs or devices7 is eligible for      
consideration and referral by the       
,director of ,,barda to the ,center if  
such drug or device incorporates a novel
 technology1 or uses an established     
technique or technology in a novel way1 
that will substantially-- 7#a7 further  
development of a drug or device of      
interest2  7#b7 fulfil an unmet need2 or
  7#c7 develop the manufacturing process
 for a drug or device4  7e7             
,international coordination ,the        
,director of ,,barda1 in collaboration  

with the ,assistant ,secretary for      
,global ,affairs and the ,center        
established under subsection 7a71 shall 
coordinate1 as appropriate1 with        
international partners to enhance global
 health security by encouraging other   
initiatives1 similar to the program     
described in subsection 7a71 under which
 international advanced development     
networks support an expanded worldwide  
strategy for vaccine1 drug1 device1 and 
other countermeasure research1          
development1 and manufacturing4  4